CD14 and glioblastoma: In addition, CD14+ levels in recurrent GBM were positively correlated with MDSC4 (Figure 4G, R = 0.714, p = 0.0374), thus reinforcing the notion that the expansion of monocytes in these patients is associated with an immune suppressive trait.